Eledon Pharmaceuticals (ELDN) Non-Current Assets (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Non-Current Assets of $33.1 million for Q1 2026, down 1.48% year-on-year from $33.6 million in Q1 2025, and down 0.68% on a QoQ basis from $33.3 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Non-Current Assets data on file, last reported at $33.1 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 1.48% year-over-year to $33.1 million; the trailing twelve-month figure through Mar 2026 stood at $133.5 million (changed 0.09% YoY), and the FY2025 full-year result was $33.3 million, down 1.05% from the prior year.
- Non-Current Assets for Q1 2026 stood at $33.1 million, down from $33.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $82.1 million in Q1 2022 and bottomed at $32.8 million in Q1 2024.
- The 5-year median for Non-Current Assets is $33.3 million (2025), against an average of $41.9 million.
- The widest annual swing landed in 2023, when Non-Current Assets slumped 59.67%; it then advanced 2.28% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $33.3 million in 2022, then slipped by 1.02% to $32.9 million in 2023, then climbed by 2.24% to $33.7 million in 2024, then decreased by 1.05% to $33.3 million in 2025, then decreased by 0.68% to $33.1 million in 2026.
- The last three Non-Current Assets figures came in at $33.1 million (Q1 2026), $33.3 million (Q4 2025), and $33.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 33.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.09 Mn |
| Dec 31, 2025 | 33.32 Mn |
| Sep 30, 2025 | 33.56 Mn |
| Jun 30, 2025 | 33.51 Mn |
| Mar 31, 2025 | 33.59 Mn |
| Dec 31, 2024 | 33.68 Mn |
| Sep 30, 2024 | 33.07 Mn |
| Jun 30, 2024 | 33.26 Mn |
| Mar 31, 2024 | 32.84 Mn |
| Dec 31, 2023 | 32.94 Mn |
| Sep 30, 2023 | 33.08 Mn |
| Jun 30, 2023 | 33.16 Mn |
| Mar 31, 2023 | 33.40 Mn |
| Dec 31, 2022 | 33.28 Mn |
| Sep 30, 2022 | 82.02 Mn |
| Jun 30, 2022 | 81.92 Mn |
| Mar 31, 2022 | 82.05 Mn |
| Dec 31, 2021 | 82.20 Mn |
| Sep 30, 2021 | 81.61 Mn |
| Jun 30, 2021 | 81.72 Mn |
| Mar 31, 2021 | 81.44 Mn |
| Dec 31, 2020 | 81.56 Mn |
| Sep 30, 2020 | 77.48 Mn |
| Jun 30, 2020 | 740,000.00 |
| Mar 31, 2020 | 847,000.00 |
| Dec 31, 2019 | 960,000.00 |
| Sep 30, 2019 | 2.92 Mn |
| Jun 30, 2019 | 3.04 Mn |
| Mar 31, 2019 | 3.13 Mn |
| Dec 31, 2018 | 2.75 Mn |
| Sep 30, 2018 | 2.82 Mn |
| Jun 30, 2018 | 1.89 Mn |
| Mar 31, 2018 | 1.89 Mn |
| Dec 31, 2017 | 1.89 Mn |
| Sep 30, 2017 | 1.98 Mn |
| Jun 30, 2017 | 2.00 Mn |
| Mar 31, 2017 | 200,000.00 |
| Dec 31, 2016 | 46,000.00 |
| Sep 30, 2016 | 387,000.00 |
| Jun 30, 2016 | 671,000.00 |
| Mar 31, 2016 | 723,000.00 |
| Dec 31, 2015 | 804,000.00 |
| Sep 30, 2015 | 742,000.00 |
| Jun 30, 2015 | 654,000.00 |
| Mar 31, 2015 | 318,000.00 |
| Dec 31, 2014 | 233,000.00 |
| Sep 30, 2014 | 259,000.00 |
| Dec 31, 2013 | 109,000.00 |